Noninferior Immunogenicity and Consistent Safety of Respiratory Syncytial Virus Prefusion F Protein Vaccine in Adults 50-59 Years Compared to ≥60 Years of Age.
Murdo FergusonTino F SchwarzSebastián A NúñezJuan Rodríguez-GarcíaMarek MitalCarlos ZalaBernhard SchmittNicole ToursarkissianDolores Ochoa MazarroJosef GroßkopfChristine Voors-PetteHemalini MehtaHiwot Amare HailemariamMagali de HeuschBruno SalaunSilvia DamasoMarie-Pierre DavidDominique DescampsJudith HillCorinne VandermeulenVeronica Hulstrømnull nullPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
ClinicalTrials.gov: NCT05590403.